129
Views
108
CrossRef citations to date
0
Altmetric
Original Article

Faecal Calprotectin: A Novel Test for the Diagnosis of Colorectal Cancer?

, , , , , & show all
Pages 1073-1076 | Received 18 Mar 1993, Accepted 07 Jun 1993, Published online: 08 Jul 2009

References

  • Winawer S J, Miller D. Screening for colorectal cancer. Bull WHO 1987; 65: 105–11
  • Fenoglio C M, Pascal R R. Colorectal adenoma and cancer. Cancer 1982; 50: 2601–8
  • Simon J B. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology 1985; 88: 820–37
  • Letsou G, Ballantyne G H, Zdon M J, Zucker K A, Modlin I M. A comparison of the faecal occult blood test and endoscopic examination. Dis Colon Rectum 1987; 30: 839–43
  • Windeler J, Köbberling J. Colorectal carcinoma and Haem-occult. Int J Colorectal Dis 1987; 2: 223–8
  • Dybdahl J H, Daae L NW, Larsen S, Myren J. Occult faecal bloodloss determined by 5lCr method and chemical tests in patients referred for colonoscopy. Scand J Gastroenterol 1984; 19: 245–54
  • Dale I, Brandtzaeg P, Fagerhol M K, Scott H. Distribution of a new myelomonocytic antigen (LI) in human peripheral blood leukocytes. Am J Clin Pathol 1985; 84: 24–34
  • Fagerhol M K, Dale I, Andersson T. Release and quantitation of a leucocyte derived protein (LI). Scand J Haematol 1980; 24: 393–8
  • Steinbakk M, Naess-Andresen C F, Lingaas E, Dale I, Brandtzaeg P, Fagerhol M K. Antimicrobial action of calcium binding leukocyte LI protein, calprotectin. Lancet 1990; 336: 763–5
  • Røseth A G, Fagerhol M K, Aadland E, Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27: 793–8
  • Cordell J L, Falini B, Erber W N, Ghosh A K, Abdulaziz Z, MacDonald S. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 2: 219–29
  • Berntzen H B, Munthe E, Fagerhol M K. The major granulocyte protein LI as an indicator of inflammatory joint disease. Scand J Rheumatol 1988; 251–6, Suppl 76
  • Bjarnason I, So A, Levi A J, Peters T, Williams P, Zanelli G D. Intestinal permeability and inflammation in rheumatoid arthritis: effect of non-steroidal anti-inflammatory drugs. Lancet 1984; 2: 1171–4
  • Mielants H, Veys E M, Goemaere S, Goethals K, Cuvelier C, De Vos M. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol 1991; 18: 1542–51
  • Brandtzaeg P, Dale I, Fagerhol M K. Distribution of a formalin resistant myelomonocytic antigen (LI) in human tissues. Am J Clin Pathol 1987; 87: 700–7
  • Dale I, Brandtzaeg P. Expression of the epithelial LI antigen as an immunohistochemical marker of squamous cell carcinoma of the lung. Histopathology 1989; 14: 493–502
  • Brandtzaeg P, Dale I, Gabrielsen T Ø. The leukocyte protein LI (calprotectin): usefulness as an immunohistochemical marker antigen and putative biological function. Histopathology 1992; 21: 191–6
  • Becker W, Schäffer R, Börner W. Sigmoid carcinoma mimicking an intra-abdominal abscess in an 111In-labeled white blood cell scan. Eur J Nucl Med 1985; 11: 283–5
  • Saverymuttu S H, Maltby P, Batman P, Joseph A E, Maxwell D. False positive localisation of 111Indium granulocytes in colonic carcinoma. Br J Radiol 1986; 59: 773–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.